Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases.
View Top Employees from Aro Biotherapeutics| Website | http://www.arobiotx.com |
| Employees | 49 (49 on RocketReach) |
| Founded | 2018 |
| Address | 3675 Market Street Suite 200, Philadelphia, Pennsylvania 19104, US |
| Technologies |
JavaScript,
HTML,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology, Oncology, Science and Engineering, Drug Discovery, Therapeutics, Drug Development, Health Care, Licensing, Drug Delivery, Sirna, Immunology, Bispecifics, Protein Conjugation, Protein Therapeutics, Oligonucleotide Delivery, Protein Engineering, Targeted Nanoparticles |
Looking for a particular Aro Biotherapeutics employee's phone or email?
Aro Biotherapeutics Questions
Scott Greenberg is the COO of Aro Biotherapeutics.
49 people are employed at Aro Biotherapeutics.
Aro Biotherapeutics is based in Philadelphia, Pennsylvania.
Top Aro Biotherapeutics Employees
-
51
-
34
-
43
-
45+
-
53
-
View
Michael Tortorici
Vice President, Nonclinical Development at Aro Biotherapeutics
Philadelphia, Pennsylvania, United States12 -
33
-
51
Related Companies
